What is Global Medical REIT Inc.'s earnings per share (EPS)?

Global Medical REIT Inc. (GMRE) reported diluted earnings per share of -$0.91 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Global Medical REIT (GMRE) Financials

GMRE NYSE

Trailing 12 months to March 31, 2026

Revenue $151.7M +9.7% YoY

Net Income -$9.0M -210.5% YoY

EPS (Diluted) -$0.91 FY2025 annual

Operating Cash Flow $74.7M +9.8% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported May 7, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the GMRE SEC filings page.

Global Medical REIT Inc. (GMRE) reported $151.7M in revenue over the twelve months to Mar 31, 2026, up 9.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GMRE FY2025 2026-10-24

Revenue is growing, but shrinking equity and widening earnings-cash-flow divergence reveal a balance sheet increasingly dependent on noncash real-estate charges.

FY2025 paired a net loss of $6.9M with operating cash flow of $73.6M; depreciation and amortization remained a large noncash charge, so reported earnings understated cash generated by the asset base. That cash flow rose 5.1% from FY2024 even as profitability deteriorated, making cash conversion look stronger than earnings alone.

FY2025 revenue reached $148.2M against a $1.2B asset base, indicating an asset-heavy model. That asset base was down 2.0% from FY2023 while revenue was up 5.1%, pointing to income being maintained without balance-sheet expansion.

Liabilities totaled $712.4M versus $509.8M of equity in FY2025, leaving obligations with a larger book claim than the capital supporting them. The liability share rose to 57.3% from 52.2% in FY2023, so the balance-sheet cushion narrowed even though reported debt-to-equity was near zero.

Financial Health Signals

Financial Health Score (4 of 6 dimensions) 66/100

Scored as: REITs peer group

Scored against REITs for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 4 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Global Medical REIT Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

FFO Margin

FFO Margin measures funds from operations against revenue, and funds from operations is net income with property depreciation added back, since a building written down a little further every year on paper is often worth more rather than less. Global Medical REIT Inc. scores 71/100 on it among other REITs.

FFO Growth

FFO Growth follows the three-year path of funds from operations, which is net income with property depreciation added back. Global Medical REIT Inc. scores 21/100 on it among other REITs.

Leverage

n/a

Not available for Global Medical REIT Inc., so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.

Interest Cov.

n/a

Not available for Global Medical REIT Inc., so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.

AFFO Margin

AFFO Margin takes funds from operations, subtracts the spending a REIT needs just to keep its properties in working order, and measures what is left against revenue. Global Medical REIT Inc. scores 76/100 on it among other REITs.

Dividend Cov.

Dividend coverage measures funds from operations against the dividends actually paid, and a figure above 1 means the payout came out of operations. Global Medical REIT Inc. scores 97/100 on it among other REITs.

Piotroski F-Score Partial

5/7

Global Medical REIT Inc. passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.

Earnings Quality Mixed

N/A

Global Medical REIT Inc. reported a net loss of $6.9M while generating $73.6M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$38.1M

YoY+10.0%

QoQ-0.9%

5Y CAGR+6.8%

10Y CAGR+40.0%

Global Medical REIT Inc. generated $38.1M in revenue in Q1 2026. This represents an increase of 10.0% from the same quarter a year earlier. Against the prior quarter it is down 0.9%.

Net Income

$1.7M

YoY-55.7%

QoQn/m

5Y CAGR-13.0%

10Y CAGRn/m

Global Medical REIT Inc. reported $1.7M in net income in Q1 2026. This represents a decrease of 55.7% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)

-$0.06

Global Medical REIT Inc. earned -$0.06 per diluted share (EPS) in Q1 2026.

EBITDA

Not reported for Q1 2026.

Cash & Balance Sheet

Cash & Debt

$8.2M

YoY+51.2%

QoQ-9.9%

5Y CAGR+9.1%

10Y CAGR+32.1%

Global Medical REIT Inc. held $8.2M in cash as of Q1 2026; no long-term debt figure is on record for that period.

Shares Outstanding

13M

QoQ0.0%

Global Medical REIT Inc. had 13M shares outstanding in Q1 2026. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q1 2026.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Net Margin

4.3%

YoY-6.4pp

QoQ+20.4pp

5Y change-7.8pp

Global Medical REIT Inc.'s net profit margin was 4.3% in Q1 2026, showing the share of revenue converted to profit. This is down 6.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 20.4 percentage points.

Return on Equity

0.3%

YoY-0.4pp

QoQ+1.5pp

5Y change-0.2pp

10Y change+15.6pp

Global Medical REIT Inc.'s quarterly ROE was 0.3% in Q1 2026: one quarter's net income over shareholder equity, not annualized. This is down 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.5 percentage points.

Gross Margin

Not reported for Q1 2026.

Operating Margin

Not reported for Q1 2026.

Capital Allocation

None of these metrics is reported for Q1 2026.

GMRE Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GMRE quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY12
Revenue	$151.7M	$148.2M+6.8%	$138.8M-1.6%	$141.0M+2.7%	$137.3M+18.4%	$115.9M+23.7%	$93.7M+32.5%	$70.7M+33.0%	$53.2M+75.3%	$30.3M+269.6%	$8.2M+298.2%	$2.1M+442.1%	$380Kn/m	$0	N/A	N/A
SG&A Expenses	$21.5M	$20.0M-5.3%	$21.1M+25.3%	$16.9M+1.9%	$16.5M+0.6%	$16.5M+37.9%	$11.9M+82.6%	$6.5M+18.0%	$5.5M+0.9%	$5.5M+30.1%	$4.2M+892.7%	$425K+1956.5%	$21Kn/m	$0-100.0%	$50K	$8K
Interest Expense	$31.8M	$31.8M+10.7%	$28.7M-7.1%	$30.9M+22.4%	$25.2M+28.1%	$19.7M+5.4%	$18.7M+6.9%	$17.5M+16.7%	$15.0M+101.4%	$7.4M+79.6%	$4.1M+172.5%	$1.5M+408.6%	$299Kn/m	$0	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0
Net Income	-$9.0M	-$6.9M-202.9%	$6.7M-69.2%	$21.7M+8.7%	$20.0M+9.0%	$18.3Mn/m	-$2.5M-126.1%	$9.6M-34.2%	$14.6Mn/m	-$87Kn/m	-$6.4Mn/m	-$1.6Mn/m	-$652K	N/A	-$50K	-$8K
EPS (Basic)	N/A	-$0.91	$0.06	$1.13	$0.20+5.3%	$0.19	-$0.17	$0.10	N/A	N/A	N/A	N/A	-$652206.00	N/A	N/A	N/A
EPS (Diluted)	—	-$0.91	$0.06	$1.13	$0.20+5.3%	$0.19	-$0.17	$0.10	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	N/A	13M	13M	13M	65M+8.0%	61M	46M	34M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Revenue	$38.1M+10.0%	$38.4M+9.2%	$37.2M+8.7%	$38.0M+10.9%	$34.6M-1.4%	$35.2M+6.7%	$34.3M-3.5%	$34.2M-5.8%
SG&A Expenses	$5.1M+40.6%	$5.5M-28.7%	$4.9M+10.9%	$6.0M+31.3%	$3.6M-18.6%	$7.7M+82.6%	$4.4M+0.3%	$4.6M+2.8%
Interest Expense	$7.2M+0.9%	$8.4M+11.0%	$8.2M+13.0%	$8.0M+14.5%	$7.2M+4.0%	$7.6M+8.4%	$7.2M+0.9%	$7.0M-17.4%
Net Income	$1.7M-55.7%	-$6.1M-309.2%	-$5.1M-249.2%	$585Kn/m	$3.7M+61.5%	$2.9M+433.4%	$3.4M-29.8%	-$2.0M-113.8%
EPS (Basic)	-$0.06	N/A	-$0.45	-$0.01n/m	$0.16	N/A	$0.14	-$0.05
EPS (Diluted)	-$0.06	N/A	-$0.45	-$0.01n/m	$0.16	N/A	$0.14	-$0.05
Diluted Shares (Avg)	13M	N/A	13M	67M+2.0%	13M	N/A	13M	66M

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA, Income Tax.

GMRE Balance Sheet

GMRE quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY12
Total Assets	$1.2B-1.1%	$1.3B-0.9%	$1.3B-9.0%	$1.4B+10.3%	$1.3B+14.8%	$1.1B+24.4%	$884.9M+39.1%	$636.1M+34.8%	$471.8M+107.6%	$227.3M+248.0%	$65.3M+193.7%	$22.2M+632033.0%	$4K	N/A	N/A
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$4K-71.4%	$12K	$47K
Cash & Equivalents	$9.1M+33.3%	$6.8M+433.3%	$1.3M-68.2%	$4.0M-44.3%	$7.2M+31.0%	$5.5M+99.2%	$2.8M-23.9%	$3.6M-28.9%	$5.1M-74.0%	$19.7M+114.2%	$9.2M+3752.2%	$238K+6674.9%	$4K-71.4%	$12K	$47K
Accounts Receivable	$7.2M-2.7%	$7.4M+9.8%	$6.8M-15.9%	$8.0M+32.5%	$6.1M+8.5%	$5.6M+12.9%	$5.0M+70.6%	$2.9M+312.6%	$704K+232.1%	$212Kn/m	$0n/m	$0	N/A	N/A	N/A
Goodwill	$5.9M0.0%	$5.9M0.0%	$5.9M0.0%	$5.9M0.0%	$5.9M0.0%	$5.9Mn/m	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$712.4M+1.7%	$700.6M+5.8%	$661.9M-11.1%	$744.2M+18.9%	$625.9M-2.7%	$643.1M+51.5%	$424.6M+26.2%	$336.3M+58.1%	$212.8M+194.4%	$72.3M+10.4%	$65.5M+227.0%	$20.0M+102986.1%	$19K	N/A	N/A
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$19K+146.5%	$8K	$380
Non-Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0	N/A	N/A
Long-Term Debt	$1.2M-92.0%	$14.4M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$15.1M	N/A	N/A	N/A
Total Equity	$509.8M-4.6%	$534.1M-8.5%	$583.6M-7.8%	$633.0M+1.6%	$622.8M+40.0%	$444.8M+3.4%	$430.3M+59.8%	$269.3M+9.3%	$246.3M+58.9%	$155.0Mn/m	-$139K-106.2%	$2.2Mn/m	-$16K-458.8%	$4K	$47K
Retained Earnings	-$350.0Mn/m	-$293.7Mn/m	-$239.0Mn/m	-$198.7Mn/m	-$157.0Mn/m	-$116.8Mn/m	-$71.4Mn/m	-$45.0Mn/m	-$34.4M	N/A	-$3.2Mn/m	-$791Kn/m	-$96K-289.7%	$51K	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Total Assets	$1.2B-2.5%	$1.2B-1.1%	$1.3B+2.5%	$1.3B+4.5%	$1.3B+0.5%	$1.3B-0.9%	$1.2B-4.6%	$1.2B-6.0%
Cash & Equivalents	$8.2M+51.2%	$9.1M+33.3%	$7.1M+24.5%	$6.6M+32.2%	$5.4M+306.0%	$6.8M+433.3%	$5.7M+346.8%	$5.0M+102.4%
Accounts Receivable	$6.8M-16.1%	$7.2M-2.7%	$7.9M-2.2%	$7.8M-3.1%	$8.1M+4.7%	$7.4M+9.8%	$8.1M+7.9%	$8.1M+9.4%
Goodwill	$5.9M0.0%	$5.9M0.0%	$5.9M0.0%	$5.9M0.0%	$5.9M0.0%	$5.9M0.0%	$5.9M0.0%	$5.9M0.0%
Total Liabilities	$717.4M-1.9%	$712.4M+1.7%	$767.4M+13.2%	$771.9M+16.5%	$731.5M+9.7%	$700.6M+5.8%	$678.0M+1.4%	$662.8M-2.4%
Long-Term Debt	N/A	$1.2M-92.0%	$1.2M-92.1%	$14.2M-3.5%	$14.3M-44.6%	$14.4M	$14.5M	$14.7M
Total Equity	$500.2M-3.3%	$509.8M-4.6%	$485.3M-10.6%	$503.2M-9.6%	$517.4M-10.0%	$534.1M-8.5%	$542.6M-11.3%	$556.4M-10.2%
Retained Earnings	-$360.6Mn/m	-$350.0Mn/m	-$332.6Mn/m	-$316.5Mn/m	-$305.7Mn/m	-$293.7Mn/m	-$281.1Mn/m	-$268.9Mn/m

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Long-Term Investments, Current Liabilities, Non-Current Liabilities.

GMRE Cash Flow Statement

GMRE quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY12
Operating Cash Flow	$74.7M	$73.6M+5.1%	$70.0M+2.3%	$68.4M-10.6%	$76.5M+11.0%	$69.0M+99.8%	$34.5M-5.2%	$36.4M+46.7%	$24.8M+97.2%	$12.6Mn/m	-$2.2Mn/m	-$209Kn/m	-$209K	N/A	-$35K	-$8K
Depreciation & Amortization	N/A	$58.0M+5.7%	$54.9M-5.3%	$58.0M+2.3%	$56.6M+21.0%	$46.8M+28.8%	$36.3M+47.4%	$24.6M+42.7%	$17.3M+72.7%	$10.0M+328.3%	$2.3M+254.0%	$660K+411.1%	$129Kn/m	$0	N/A	N/A
Stock-Based Compensation	N/A	$4.5M-11.9%	$5.1M+20.3%	$4.2M-9.4%	$4.7M-19.4%	$5.8M+9.2%	$5.3M+59.4%	$3.3M+24.9%	$2.7M+48.7%	$1.8M+6.6%	$1.7Mn/m	$0	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$31.8M+45.3%	$21.9M	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$32.0Mn/m	-$22.1M	N/A	N/A	N/A
Investing Cash Flow	-$43.0M	-$60.4Mn/m	-$45.9M-167.9%	$67.6Mn/m	-$137.3Mn/m	-$194.7Mn/m	-$223.7Mn/m	-$258.2Mn/m	-$151.6Mn/m	-$252.7Mn/m	-$150.4Mn/m	-$32.3Mn/m	-$21.9Mn/m	$0	N/A	N/A
Financing Cash Flow	-$28.3M	-$10.3Mn/m	-$21.9Mn/m	-$143.8M-330.4%	$62.4M-51.1%	$127.7M-33.7%	$192.7M-14.0%	$224.1M+80.0%	$124.5M-45.0%	$226.6M+38.6%	$163.5M+292.6%	$41.6M+87.2%	$22.3M	N/A	$0	$55K
Dividends Paid	$15.3M	$5.8M0.0%	$5.8M0.0%	$5.8M0.0%	$5.8M0.0%	$5.8M0.0%	$5.8M0.0%	$5.8M0.0%	$5.8M+681.3%	$745Kn/m	$0n/m	$0-100.0%	$43Kn/m	$0	N/A	N/A
Share Buybacks	N/A	$6.0M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Cash Flow	$13.4M+8.8%	$21.6M+5.4%	$17.6M+7.8%	$22.1M+17.0%	$12.3M-14.1%	$20.5M+13.2%	$16.3M-2.2%	$18.9M+5.9%
Depreciation & Amortization	$14.5M+6.7%	$21.9M+5.3%	$11.2M+12.2%	$11.3M+11.7%	$13.6M-2.7%	$20.8M-7.6%	$10.0M-1.1%	$10.1M-3.3%
Stock-Based Compensation	$1.2M+713.9%	N/A	$1.2M-5.3%	$1.7M+31.0%	$151K-87.8%	N/A	$1.3M+7.5%	$1.3M+15.0%
Investing Cash Flow	-$9.8Mn/m	$6.7Mn/m	-$703Kn/m	-$39.2M-2297.5%	-$27.2Mn/m	-$19.5Mn/m	-$25.5M-550.0%	$1.8M-97.1%
Financing Cash Flow	-$4.4M-132.6%	-$26.3M-17310.5%	-$16.2M-277.4%	$18.7Mn/m	$13.6Mn/m	$153Kn/m	$9.2Mn/m	-$20.7Mn/m
Dividends Paid	$10.9M+651.8%	$1.5M0.0%	$1.5M0.0%	$1.5M0.0%	$1.5M0.0%	$1.5M0.0%	$1.5M0.0%	$1.5M0.0%

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Share Buybacks.

GMRE Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GMRE quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY12
Net Margin	-4.6%-9.5pp	4.8%-10.6pp	15.4%+0.8pp	14.6%-1.3pp	15.8%+18.5pp	-2.7%-16.2pp	13.6%-13.8pp	27.4%+27.7pp	-0.3%+77.1pp	-77.4%+0.7pp	-78.0%	-171.4%	N/A	N/A	N/A
Return on Equity	-1.4%-2.6pp	1.3%-2.5pp	3.7%+0.6pp	3.2%+0.2pp	2.9%+3.5pp	-0.6%-2.8pp	2.2%-3.2pp	5.4%+5.5pp	0.0%+4.1pp	-4.1%	N/A	-29.4%	N/A	-1130.3%	-17.5%
Return on Assets	-0.5%-1.1pp	0.5%-1.2pp	1.7%+0.3pp	1.4%0.0pp	1.5%+1.7pp	-0.2%-1.3pp	1.1%-1.2pp	2.3%+2.3pp	0.0%+2.8pp	-2.8%-0.3pp	-2.5%+0.5pp	-2.9%	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	0.18-1.4x	1.56	124.18
Debt-to-Equity	0.000.0x	0.03	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	6.78	N/A	N/A	N/A
Liabilities-to-Equity	1.40+0.1x	1.31+0.2x	1.130.0x	1.18+0.2x	1.00-0.4x	1.45+0.5x	0.99-0.3x	1.25+0.4x	0.86+0.4x	0.47	N/A	9.01	N/A	N/A	N/A
Asset Turnover	0.120.0x	0.110.0x	0.110.0x	0.100.0x	0.090.0x	0.090.0x	0.080.0x	0.080.0x	0.060.0x	0.040.0x	0.030.0x	0.020.0x	0.00	N/A	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-1550.6%	-5803.3%	N/A	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Net Margin	4.3%-6.4pp	-16.0%-24.4pp	-13.6%-23.5pp	1.5%+7.2pp	10.8%+4.2pp	8.4%+6.7pp	9.9%-3.7pp	-5.7%-44.7pp
Return on Equity	0.3%-0.4pp	-1.2%-1.8pp	-1.0%-1.7pp	0.1%+0.5pp	0.7%+0.3pp	0.5%+0.5pp	0.6%-0.2pp	-0.4%-2.6pp
Return on Assets	0.1%-0.2pp	-0.5%-0.7pp	-0.4%-0.7pp	0.1%+0.2pp	0.3%+0.1pp	0.2%+0.2pp	0.3%-0.1pp	-0.2%-1.2pp
Debt-to-Equity	N/A	0.000.0x	0.000.0x	0.030.0x	0.030.0x	0.03	0.03	0.03
Liabilities-to-Equity	1.430.0x	1.40+0.1x	1.58+0.3x	1.53+0.3x	1.41+0.3x	1.31+0.2x	1.25+0.2x	1.19+0.1x
Asset Turnover	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.030.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Global Medical REIT Inc. GMRE	FY2025	$148.2M	-$6.9M	-4.6%	N/A	66/100
Diversified Healthcare Trust DHC	FY2025	$1.5B	-$285.9M	-18.6%	$1.9B	11/100
Strawberry Fields REIT, Inc. STRW	FY2025	$155.0M	$7.6M	4.9%	$178.1M	64/100
LTC Properties, Inc. LTC	FY2025	$262.9M	$118.0M	44.9%	$2.4B	56/100
Universal Health Realty Income Trust UHT	FY2025	$99.2M	$17.6M	17.8%	$526.4M	52/100

Where Global Medical REIT Inc. Ranks

Frequently Asked Questions

What is Global Medical REIT Inc.'s annual revenue?

Global Medical REIT Inc. (GMRE) reported $148.2M in total revenue for fiscal year 2025. This represents a 6.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Global Medical REIT Inc.'s revenue growing?

Global Medical REIT Inc. (GMRE) revenue grew by 6.8% year-over-year, from $138.8M to $148.2M in fiscal year 2025.

Is Global Medical REIT Inc. profitable?

No, Global Medical REIT Inc. (GMRE) reported a net loss of $9.0M over the trailing 12 months to March 31, 2026. In fiscal year 2025 it reported a net loss of $6.9M, with a net profit margin of -4.6%.

How much debt does Global Medical REIT Inc. have?

As of fiscal year 2025, Global Medical REIT Inc. (GMRE) had $9.1M in cash and equivalents against $1.2M in long-term debt.

What is Global Medical REIT Inc.'s net profit margin?

Global Medical REIT Inc. (GMRE) had a net profit margin of -4.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Global Medical REIT Inc.'s return on equity (ROE)?

Global Medical REIT Inc. (GMRE) has a return on equity of -1.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Global Medical REIT Inc.'s operating cash flow?

Global Medical REIT Inc. (GMRE) generated $73.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Global Medical REIT Inc.'s total assets?

Global Medical REIT Inc. (GMRE) had $1.2B in total assets as of fiscal year 2025, including both current and long-term assets.

Does Global Medical REIT Inc. buy back shares?

Yes, Global Medical REIT Inc. (GMRE) spent $6.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Global Medical REIT Inc. have outstanding?

Global Medical REIT Inc. (GMRE) had 13M shares outstanding as of fiscal year 2025.

What is Global Medical REIT Inc.'s debt-to-equity ratio?

Global Medical REIT Inc. (GMRE) had a debt-to-equity ratio of 0.00 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

What is Global Medical REIT Inc.'s liabilities-to-equity ratio?

Global Medical REIT Inc. (GMRE) had a liabilities-to-equity ratio of 1.40 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

What is Global Medical REIT Inc.'s return on assets (ROA)?

Global Medical REIT Inc. (GMRE) had a return on assets of -0.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Global Medical REIT Inc.'s Piotroski F-Score?

Global Medical REIT Inc. (GMRE) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Global Medical REIT Inc.'s earnings high quality?

Global Medical REIT Inc. (GMRE) reported a net loss of $6.9M while generating $73.6M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Global Medical REIT Inc.?

Global Medical REIT Inc. (GMRE) scores 66 out of 100 on our Financial Health Score, indicating strong standing within its REITs peer group. The score is the average of six dimensions (FFO Margin, FFO Growth, Leverage, Interest Cov., AFFO Margin, Dividend Cov.), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Global Medical REIT Inc. it averages the 4 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.